Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback